Eden Research (LON:EDEN) Shares Down 0.2% – What’s Next?

Shares of Eden Research plc (LON:EDEN) traded down 0.2% on Friday . The company traded as low as GBX 3.59 ($0.05) and last traded at GBX 3.59 ($0.05). 10,000 shares traded hands during mid-day trading, a decline of 99% from the average session volume of 920,772 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Stock Down 0.2 %

The company has a current ratio of 3.80, a quick ratio of 2.42 and a debt-to-equity ratio of 1.26. The firm has a 50 day moving average price of GBX 3.88 and a 200-day moving average price of GBX 3.95. The firm has a market cap of £19.17 million, a price-to-earnings ratio of -12.59 and a beta of 0.92.

Insider Buying and Selling at Eden Research

In other Eden Research news, insider Alexander John Abrey bought 540,540 shares of the company’s stock in a transaction that occurred on Tuesday, January 28th. The stock was purchased at an average price of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($27,396.86). Also, insider Lykele van der Broek bought 256,000 shares of Eden Research stock in a transaction that occurred on Thursday, February 6th. The shares were acquired at an average price of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($12,975.16). 14.02% of the stock is currently owned by insiders.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.